MEL USED TO TREAT VITILIGO

A pilot study conducted by researchers in Rome used monochromatic excimer light (MEL) to treat 37 vitiligo patients twice weekly with MEL for a maximum of six months.

Related Videos
Experts discuss plaque psoriasis.
Experts discuss plaque psoriasis.
Related Content

Previewing Fall Clinical PA & NP Conference With James Del Rosso, DO

May 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial

May 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pointers With Portela: Products to Build a Skin Care Routine

May 31st 2023

Michael Cameron, MD, FAAD, Shares Challenges, Insights Into Opening a New Practice

May 31st 2023

Previewing Fall Clinical PA & NP Conference With James Del Rosso, DO

May 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial

May 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pointers With Portela: Products to Build a Skin Care Routine

May 31st 2023

Michael Cameron, MD, FAAD, Shares Challenges, Insights Into Opening a New Practice

May 31st 2023

Previewing Fall Clinical PA & NP Conference With James Del Rosso, DO

May 31st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Janssen Announces Positive Results From Guselkumab Psoriatic Arthritis Trial

May 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pointers With Portela: Products to Build a Skin Care Routine

May 31st 2023

Michael Cameron, MD, FAAD, Shares Challenges, Insights Into Opening a New Practice

May 31st 2023
© 2023 MJH Life Sciences

All rights reserved.